AXIOMER Trademark

Trademark Overview


On Wednesday, March 23, 2016, a trademark application was filed for AXIOMER with the United States Patent and Trademark Office. The USPTO has given the AXIOMER trademark a serial number of 79192823. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, January 12, 2024. This trademark is owned by ProQR Therapeutics II B.V.. The AXIOMER trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

[ Pharmaceutical preparations for the treatment, diagnosis and prevention of genetic diseases and disorders; ] pharmaceutical preparations for the treatment of genetic diseases based on oligonucleotides, [ oligoribonucleotides, aptamers, nucleic acid molecules, dna, ] * for use in * rna [, polynucleotides, ribozymes, mirnas, snornas, mrnas or sirnas ]

[ Chemical compounds for scientific or research purposes ]

[ Laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; laboratory research and analysis in the field of medicines; services of biotechnological, chemical and pharmacological laboratories, including scientific and technological research, in relation to the production of chemicals and biotechnological products for use in the preparation of pharmaceuticals; development of pharmaceutical preparations and medicines; development of technologies for the production of pharmaceutical semi finished and/or finished preparations; academic research, medical and biochemical research and development services; chemistry, laboratory technicians' and engineering services; research and development in the field of biotechnology; research into and development and testing of pharmaceutical and biochemical semi- finished products, in particular for use in medicines, research into and development and testing of medicines; development of test syst...
axiomer

General Information


Serial Number79192823
Word MarkAXIOMER
Filing DateWednesday, March 23, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, January 12, 2024
Registration Number5229979
Registration DateTuesday, June 27, 2017
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 10, 2017

Trademark Statements


Certificate of Correction for RegistrationIn the heading, Int. Cl. 1 and Int. Cl. 42 should be deleted. In the statement line 5 and lines 10-22, should deleted. In the statement, lines 6-9, should be deleted, except "pharmaceutical preparations for the treatment of genetic diseases based on oligonucleotides, rna". In the statement, line 8, before "rna" "for use in" should be inserted.
Goods and Services[ Pharmaceutical preparations for the treatment, diagnosis and prevention of genetic diseases and disorders; ] pharmaceutical preparations for the treatment of genetic diseases based on oligonucleotides, [ oligoribonucleotides, aptamers, nucleic acid molecules, dna, ] * for use in * rna [, polynucleotides, ribozymes, mirnas, snornas, mrnas or sirnas ]
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Services[ Chemical compounds for scientific or research purposes ]
Goods and Services[ Laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; laboratory research and analysis in the field of medicines; services of biotechnological, chemical and pharmacological laboratories, including scientific and technological research, in relation to the production of chemicals and biotechnological products for use in the preparation of pharmaceuticals; development of pharmaceutical preparations and medicines; development of technologies for the production of pharmaceutical semi finished and/or finished preparations; academic research, medical and biochemical research and development services; chemistry, laboratory technicians' and engineering services; research and development in the field of biotechnology; research into and development and testing of pharmaceutical and biochemical semi- finished products, in particular for use in medicines, research into and development and testing of medicines; development of test systems for pharmaceutical, medical and sanitizing preparations; services development and identification of and research into new drug targets ]

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeA - Sec. 7(d) - Class(es) in a Multiple Class Registration
Class Status DateThursday, October 6, 2016
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeA - Sec. 7(d) - Class(es) in a Multiple Class Registration
Class Status DateThursday, October 6, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameProQR Therapeutics II B.V.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNL

Party NameProQR Therapeutics II B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNL

Party NameProQR Therapeutics II B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNL

Trademark Events


Event DateEvent Description
Tuesday, October 11, 2016APPLICATION FILING RECEIPT MAILED
Saturday, October 1, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, October 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 6, 2016ASSIGNED TO EXAMINER
Thursday, October 6, 2016NON-FINAL ACTION WRITTEN
Friday, October 7, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 27, 2016REFUSAL PROCESSED BY MPU
Thursday, October 27, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 11, 2016REFUSAL PROCESSED BY IB
Thursday, December 1, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 1, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 6, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, December 1, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 2, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 21, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 10, 2017PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 24, 2017EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, June 27, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, September 27, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, September 28, 2017FINAL DISPOSITION PROCESSED
Thursday, September 28, 2017FINAL DISPOSITION NOTICE SENT TO IB
Saturday, October 28, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, April 20, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, June 23, 2017LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, August 8, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 8, 2017CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, August 8, 2017LIMITATION FROM THE IB EXAMINED AND ENTERED
Monday, June 27, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, January 12, 2024CANCELLED SECTION 71
Friday, September 13, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, September 14, 2024INVALIDATION PROCESSED
Saturday, September 14, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, October 7, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, April 12, 2018INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Sunday, April 8, 2018PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED